deCODE Cancer

deCODE Ovarian Cancer test

Looks at one marker that defines the 46% of the population that has 1.13 fold the general population risk (13% increase) of ovarian cancer.

Back to deCODE Cancer Login to order test

The deCODE Cancer Scan detects the same risk factors and markers included in our individual tests for:

Breast Cancer (deCODE BreastCancer™) and
Prostate Cancer (deCODE ProstateCancer™)

together with:

Basal Cell Carcinoma, Bladder Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Testicular Cancer and Thyroid Cancer.

Ovarian cancer

Screening and prevention

How the deCODE Ovarian Cancer test can help.

Screening the general public for ovarian cancer is not recommended by any professional organization.

CancerHelp UK and The American Cancer Society recommends that women with 2 or more relatives on the same side of the family diagnosed with ovarian cancer or breast cancer at a young age (before 50) should be screened for ovarian cancer and counselled for possible genetic testing because of possible familial form of the disease, possibly caused by mutations in the BRCA genes.

The deCODE marker for ovarian cancer are not associated with the familial form of the disease or the association with breast cancer and BRCA mutations.

Having as a complete picture of the patient’s risk as possible, including genetic risk, is always important when giving advice or making decisions about screening and intervention.

deCODE’s Ovarian Cancer Test marker (rs3814113) has been shown to associate with increased risk of women to develop epithelial cancer of the ovaries (>80 of all ovarian cancer).

At present, the necessary scientific information to interpret the genetic risk for individuals of other ethnicities than of European ancestry is not available.

This content was last reviewed on January 25, 2011.